Skip to main content
CRL
NYSE Life Sciences

Charles River Bolsters CRO Services With Frontage Bioanalysis, DMPK Buy

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$337.44
Mkt Cap
$16.113B
52W Low
$146.195
52W High
$379.63
52W Position info
131% above low
Off High info
11% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

CRL has more than doubled off its 52-week low of $146.195.

Summary

Charles River agreed to acquire Frontage's bioanalysis and DMPK businesses for about $470 million, with potential additional payments of up to $75 million, adding lab-service capabilities to its drug-discovery and development franchise. The acquired businesses represented about 40% of Frontage's 2025 revenue of $256.7 million. Charles River will finance the deal through a credit facility and available cash. The move comes days after Charles River beat Q3 expectations and raised 2026 guidance, giving it momentum and balance-sheet room to bolt on capabilities. Frontage's bioanalysis and DMPK work sits squarely in the outsourced lab niche Charles River already serves, so this is a tuck-in that broadens its early-stage service menu rather than a thesis-changing bet. Charles River is participating in a consortium with Hangzhou Tigermed Consulting and Song Li to take Frontage private.

At the time of this announcement, CRL was trading at $337.44 on NYSE in the Life Sciences sector, with a market capitalization of approximately $16.1B. The 52-week trading range was $146.20 to $379.63. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

CRL - Latest Insights

CRL
Nov 04, 2026, 9:03 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $342.99
Real-time Price: $337.44 info
Change: -$5.55 (-2%) info
Market Cap: $16.113B info
CRL
Nov 04, 2026, 7:04 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $362.01
Real-time Price: $337.44 info
Change: -$24.57 (-7%) info
Market Cap: $16.113B info
CRL
Nov 04, 2026, 7:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $362.00
Real-time Price: $337.44 info
Change: -$24.56 (-7%) info
Market Cap: $16.113B info
CRL
Sep 24, 2026, 8:12 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $278.01
Real-time Price: $337.44 info
Change: +$59.43 (+21%) info
Market Cap: $16.113B info
CRL
Sep 24, 2026, 8:00 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $277.33
Real-time Price: $337.44 info
Change: +$60.11 (+22%) info
Market Cap: $16.113B info